News | April 28, 2026
AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
The approval was driven by data from the Phase III TULIP-SC trial
The approval was driven by data from the Phase III TULIP-SC trial
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The new assay consolidates screening for four major viral threats into a single workflow
Capital infusion to accelerate Earendil’s R&D platform
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Subscribe To Our Newsletter & Stay Updated
